Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">Gapping up/down: MCHP +8%, CTSH +5%, PNRA +3% and SNY +2% after earnings, TWTR +2% after upgrade; GILD -7%, CG -6%, NTGR -5%, BWLD -4% and URBN -3% after earnings<p><strong>Gapping up<br/> In reaction to strong earnings/guidance</strong>:</p><ul><li><strong>COHR</strong> +15.3%, <strong>MYGN</strong> +13.6%, <strong>JIVE</strong> +10.1%, <strong>PSDV</strong> +9.6%, <strong>MCHP</strong> +7.7%, <strong>CTSH</strong> +5.1%, <strong>CNO</strong> +4.5%, <strong>ALK</strong> +4.3%, <strong>PIR</strong> +3.8%, (reiterates Q4 guidance)</li><li><strong>CAMT</strong> +3.3%, <strong>YUMC</strong> +3.1%, (also announces $300 mln buyback; promotes KFC CEO to COO), <strong>TWLO</strong> +2.9%, <strong>PNRA</strong> +2.7%, <strong>SNY</strong> +2.2%, <strong>EMKR</strong> +2.1%</li><li><strong>IPHI</strong> +2.1%, <strong>GNW</strong> +2%, <strong>SYT</strong> +1.9%, <strong>GRA</strong> +1.7%, <strong>CALD</strong> +1.6%, <strong>AGN</strong> +1.4%, <strong>NUAN</strong> +1.3%, <strong>FARM</strong> +0.5%, <strong>LUV</strong> +0.5%, <strong>ARCH</strong> +0.5%, <strong>TWX</strong> +0.5%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>TIME</strong> +2.1% (Meredith (MDP) and group of investors might move ahead with acquisition of TIME, according to WSJ)</li></ul><p><strong>Select metals/mining stocks trading higher</strong>:</p><ul><li><strong>HMY</strong> +4%, <strong>KGC</strong> +2.5%, <strong>AG</strong> +2.1%, <strong>AU</strong> +1.7%, <strong>GDX</strong> +1.4%, <strong>NEM</strong> +1.2%, <strong>GFI</strong> +1.1%, <strong>ABX</strong> +1.1%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>APOP</strong> +11.5% (treated the first blood cancer patient in the recently initiated Phase I/II trial of its stem cell technology ApoGraft)</li><li><strong>GALT</strong> +6.3% (announces combination immunotherapy with Galectin-3 inhibitor GR-MD-02 'enhances' effects in pre-clinical models and early results of phase 1 clinical trials; data presented at the GTCBio Immunotherapeutics Conference)</li><li><strong>CRCM</strong> +4.2% (continued strength)</li><li><strong>HT</strong> +3.5% (will replace WCI Communities in the S&P SmallCap 600)</li><li><strong>CTB</strong> +2.6% (will replace comScore in the S&P MidCap 400)</li><li><strong>EIX</strong> +1% (California Utilities' settlement agreement)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>USAK</strong> +3% (upgraded to Mkt Perform from Mkt Underperform at Avondale)</li><li><strong>TWTR</strong> +2.4% (upgraded to Buy at BTIG Research)</li><li><strong>MOMO</strong> +1.1% (initiated with a Buy at Jefferies)</li><li><strong>PNC</strong> +0.8% (added to Conviction Buy List at Goldman)</li></ul><p><strong>Gapping down<br/> In reaction to disappointing earnings/guidance</strong>:</p><ul><li><strong>USNA</strong> -19.2%, <strong>TDW</strong> -16.7%, (also updates status of discussions with lenders and notehoders), <strong>SPSC</strong> -13.3%, <strong>TCX</strong> -11.5%, <strong>ORBK</strong> -9.3%, <strong>WAIR</strong> -6.7%</li><li><strong>DRYS</strong> -6.6%, <strong>ZG</strong> -6.5%, <strong>GILD</strong> -6.3%, <strong>CG</strong> -5.5%, <strong>NTGR</strong> -4.8%, <strong>ULTI</strong> -4.5%, <strong>PAA</strong> -4%, <strong>BWLD</strong> -4%, <strong>AKAM</strong> -3.7%</li><li><strong>URBN</strong> -2.9%, (reports prelim Q4 (Jan) sales of $1.03 bln vs. $1.05 bln Capital IQ Consensus Estimate), <strong>TCS</strong> -2.8%</li><li><strong>ABB</strong> -2.8%, <strong>AWRE</strong> -2.7%, <strong>MDLZ</strong> -1.3%, <strong>LPX</strong> -1.3%, <strong>NEWR</strong> -1.2%</li></ul><p><strong>M&A news</strong>:</p><ul><li><strong>PE</strong> -7.3% (to acquire oil/gas properties in Midland Basin from Double Eagle Energy Permian for approx $2.8 bln, prices 36 mln shares of Class A common stock for total gross proceeds $1.116 bln)</li></ul><p><strong>Select EU financial related names showing weakness</strong>:</p><ul><li><strong>CS</strong> -3.3%, <strong>SAN</strong> -2.2%, <strong>BBVA</strong> -2.1%, <strong>DB</strong> -1.9%, <strong>HSBC</strong> -0.8%</li></ul><p><strong>Select oil/gas related names showing early weakness</strong>:</p><ul><li><strong>PBR</strong> -1.7%, <strong>RDS.A</strong> -1.5%, <strong>RIG</strong> -1.1%, <strong>CHK</strong> -0.8%, <strong>SDRL</strong> -0.6%</li></ul><p><strong>Other news</strong>:</p><ul><li><strong>GALE</strong> -22.1% (to issue/sell shares of common stock and warrants to purchase shares of common stock; amends Purchase Agreement with Lincoln Park Capital to decrease the value of common stock of the Company that it may sell to Lincoln Park from $55 mln to $15.6 mln)</li><li><strong>EYES</strong> -12.7% (pulling back following yesterday's 78% move higher)</li><li><strong>CHRS</strong> -9% (commences an underwritten public offering of $125,000,000 of shares of its common stock)</li><li><strong>GMLP</strong> -6.7% (prices offering of 4.5 mln common units for gross proceeds of $103.5 mln)</li><li><strong>DCIX</strong> -4.4% (DRYS sympathy)</li><li><strong>AMC</strong> -4.3% (upsizes and prices offering of 19,047,619 shares of Class A common stock at $31.50 per share)</li><li><strong>FXCM</strong> -4.3% (Gain Capital enters into definitive agreement to acquire the client base of FXCM's U.S. operations; terms not disclosed)</li><li><strong>NE</strong> -2.1% (possibly TDW sympathy)</li><li><strong>PVG</strong> -0.8% (is offering $90,000,000 aggregate principal amount of unsecured convertible senior subordinated notes due 2022 pursuant to private placement)</li></ul><p><strong>Analyst comments</strong>:</p><ul><li><strong>YY</strong> -0.8% (initiated with Hold at Jefferies)</li></ul></td> </tr></table>"